Acrospire Investment Management LLC - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 31 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$7,000
-30.0%
5,769
-32.1%
0.01%
-12.5%
Q1 2017$10,000
-52.4%
8,501
-41.7%
0.01%
-11.1%
Q4 2016$21,000
+2000.0%
14,585
+1911.7%
0.01%
+800.0%
Q3 2016$1,000
-90.0%
725
-90.0%
0.00%
-85.7%
Q2 2016$10,0007,2250.01%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Verity Asset Management, Inc. 85,378$301,0000.33%
Tower Research Capital LLC (TRC) 54,690$193,0000.03%
Psagot Value Holdings Ltd. 54,348$191,0000.01%
OPPENHEIMER & CO INC 36,450$128,0000.00%
MEEDER ASSET MANAGEMENT INC 2,900$10,0000.00%
TWO SIGMA INVESTMENTS, LP 34,571$121,0000.00%
Commonwealth Equity Services, Inc 11,100$39,0000.00%
GROUP ONE TRADING, L.P. 18,844$66,0000.00%
CITIGROUP INC 737$3,0000.00%
VAN ECK ASSOCIATES CORP 21,179$75,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders